Suchergebnisse - "Ungaro, Ryan C"

PubPharm (6)

1

Impact of Concomitant 5-Aminosalicylic Acid Therapy on Vedolizumab Efficacy and Safety in Inflammatory Bowel Disease : Post Hoc Analyses of Clinical Trial Data

enthalten in: Journal of Crohn's & colitis | 2023

von Ungaro, R. | Kadali, H. | Zhang, W. | +2

2

Net Remission Rates with Biologic and Small Molecule Treatment in Ulcerative Colitis : A Reappraisal of the Clinical Trial Data

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Kayal, M. | Posner, H. | Spencer, E. | +3

3

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease : Analysis of More Than 6000 Patients From an International Registry

enthalten in: Gastroenterology | 2022

von Ungaro, R. | Brenner, E. | Agrawal, M. | +12

CommentIn: Gastroenterology. 2022 Jul;163(1):338-339. - PMID 35288110

4

Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease : Results From Two International Databases

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2021

von Brenner, E. | Pigneur, B. | Focht, G. | +6

5

Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2020

von Ungaro, R. | Limketkai, B. | Jensen, C. | +7

6

Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes : analysis of two nationwide population-based cohorts

enthalten in: Gut | 2019

von Ungaro, R. | Limketkai, B. | Jensen, C. | +5

1
[1]